Healthcare workers' exposure to hazardous drugs can have serious health effects, including cancers, infertility, and other adverse health effects. Innovative inroads are occurring to create safer devices for clinicians.
A thirteen-center U.S. site study indicated that a Closed System Transfer Device (CSTD) reduced surface contamination in both the mixing and administration of antineoplastic hazardous drugs (AHDs). The device is the Corvida Medical's Halo®, and its straightforward goal is to protect healthcare professionals from exposure to hazardous drugs, such as those used in chemotherapy.
Corvida Medical tested the device under severe conditions to challenge its fourteen fluid connections. The result is that the Halo dry-to-dry seal connections can effectively prevent microbial ingress when used with aseptic swabbing techniques. To substantiate those findings even more, Halo received an ONB product code classification from the FDA, demonstrating no escape of hazardous drug or vapor concentration, no transfer of environmental contaminants, and prevention of microbial ingress.
Corvida Medical has made its mark in designing smarter, simpler solutions for the safe handling of hazardous drugs and excellence in design.
This post is related to:CSTD (Closed System Transfer Devices)